REFERENCES
- Basile D P, Fredrich K, Weihrauch D, Hattan N, Chilian W M. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol. 2004; 286: F893–F902
- Buckwalter J B, Curtis V C, Valic Z, Ruble S B, Clifford P S. Endogenous vascular remodeling in ischemic skeletal muscle: a role for nitric oxide. J Appl Physiol 2003; 94: 935–940
- Frisbee J C, Balch Samora J, Peterson J, Bryner R. Exercise training blunts microvascular rarefaction in the metabolic syndrome. Am J Physiol Heart Circ Physiol 2006; 291: H2483–H2492
- Frisbee J C. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 2005; 289: R307–R316
- Frisbee J C. Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Microcirculation 2005; 12: 383–392
- Frisbee J C. Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol 2003; 285: H104–H111
- Frisbee J C. Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2003; 285: R1124–R1134
- Greene A S, Lombard J H, Cowley A W, Jr., Hansen-Smith F M. Microvessel changes in hypertension measured by Griffonia simplicifolia I lectin. Hypertension 1990; 15: 779–783
- Guerre-Millo M. Regulation of ob gene and overexpression in obesity. Biomed Pharmacother 1997; 51: 318–323
- Kiefer F N, Misteli H, Kalak N, Tschudin K, Fingerle J, Van der Kooij M, Stumm M, Sumanovski L T, Sieber C C, Battegay E J. Inhibition of NO biosynthesis, but not elevated blood pressure, reduces angiogenesis in rat models of secondary hypertension. Blood Press 2002; 11: 116–124
- Kondo T, Kobayashi K, Murohara T. Nitric oxide signaling during myocardial angiogenesis. Mol Cell Biochem 2004; 264: 25–34
- Kubis N, Besnard S, Silvestre J S, Feletou M, Huang P L, Levy B I, Tedgui A. Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens 2002; 20: 273–280
- Matsunaga T, Warltier D C, Weihrauch D W, Moniz M, Tessmer J, Chilian W M. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102: 3098–3103
- Milkiewicz M, Ispanovic E, Doyle J L, Haas T L. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 2006; 38: 333–357
- Milkiewicz M, Hudlicka O, Brown M D, Silgram H. Nitric oxide, VEGF, VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol. 2005; 289: H336–H343
- Stamler J S, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001; 81: 209–237
- Toyota E, Matsunaga T, Chilian W M. Myocardial angiogenesis. Mol Cell Biochem 2004; 264: 35–44
- Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher A M, Kaszkin M, Dimmeler S. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J 2002; 16: 706–708
- Wahl M L, Kenan D J, Gonzalez-Gronow M, Pizzo S V. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated. J Cell Biochem. 2005; 96: 242–261